<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://brn.sagepub.com">
<title>Biological Research For Nursing RSS feed -- OnlineFirst Articles</title>
<link>http://brn.sagepub.com</link>
<description>Biological Research For Nursing RSS feed -- OnlineFirst Articles</description>
<prism:publicationName>Biological Research For Nursing</prism:publicationName>
<prism:issn>1099-8004</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409352377v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409352237v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409341175v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409339625v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409348328v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409343311v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409343204v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409340052v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409339206v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409337731v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409337526v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409337330v1?rss=1" />
  <rdf:li rdf:resource="http://brn.sagepub.com/cgi/content/abstract/1099800409336868v1?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://brn.sagepub.com:80/icons/banner/title.gif" />
</channel>

<image rdf:about="http://brn.sagepub.com:80/icons/banner/title.gif">
<title>Biological Research For Nursing</title>
<url>http://brn.sagepub.com:80/icons/banner/title.gif</url>
<link>http://brn.sagepub.com</link>
</image>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409352377v1?rss=1">
<title><![CDATA[Inflammation in Aging Part 2: Implications for the Health of Older People and Recommendations for Nursing Practice]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409352377v1?rss=1</link>
<description><![CDATA[
<p>Aging is accompanied by declining function and remodeling of body systems. In particular, changes to the immune and endocrine systems have far-reaching effects that cause an increase in cytokine release and decrease in anti-inflammatory feedback systems. The chronic inflammation that ensues has been named "inflammaging." Inflammaging is associated with many detrimental effects that combine to increase morbidity and mortality. The sickness behavior that arises from inflammatory processes and the side effects of chronic diseases lead to a constellation of symptoms that decrease quality of life and affect the well-being of the individual. Part 2 of this two-part article provides an overview of the health effects of inflammaging, addressing the extent to which it contributes to the syndromes of frailty and disability with aging.
]]></description>
<dc:creator><![CDATA[Hunt, K. J., Walsh, B. M., Voegeli, D., Roberts, H. C.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 22:46:31 PST</dc:date>
<dc:identifier>info:doi/10.1177/1099800409352377</dc:identifier>
<dc:title><![CDATA[Inflammation in Aging Part 2: Implications for the Health of Older People and Recommendations for Nursing Practice]]></dc:title>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409352237v1?rss=1">
<title><![CDATA[Inflammation in Aging Part 1: Physiology and Immunological Mechanisms]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409352237v1?rss=1</link>
<description><![CDATA[
<p>During the aging process, remodeling of several body systems occurs, and these changes can have a startling effect upon the immune system. The reduction in sex steroids and growth hormones and declines in vitamin D concentration that accompany the aging process are associated with increases in the baseline levels of inflammatory proteins. At the same time, inflammation arising from atherosclerosis and other chronic diseases further contributes to the inflammatory milieu and effects a state of chronic inflammation. This chronic inflammation, or "inflammaging" as it has been termed, seems to be associated with a host of adverse effects contributing to many of the health problems that increase morbidity and decrease both quality of life and the ability to maintain independence in old age. For nurses to be truly informed when caring for older people and to ensure that they have a detailed understanding of the complexities of older people&rsquo;s health needs, they must have a knowledge of the physiological and immunological changes with age. This is the first of a two-part article on inflammatory processes in aging. These age-related changes are presented here, including an examination of the impact of genetic and lifestyle factors. The effect of these changes on the health of the individual and implications for practice are described in Part 2.
]]></description>
<dc:creator><![CDATA[Hunt, K. J., Walsh, B. M., Voegeli, D., Roberts, H. C.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 22:46:30 PST</dc:date>
<dc:identifier>info:doi/10.1177/1099800409352237</dc:identifier>
<dc:title><![CDATA[Inflammation in Aging Part 1: Physiology and Immunological Mechanisms]]></dc:title>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409341175v1?rss=1">
<title><![CDATA[A Longitudinal Description of Heart Rate Variability in 28-34-Week-Old Preterm Infants]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409341175v1?rss=1</link>
<description><![CDATA[
<p>The purpose of this study was to longitudinally describe changes in heart rate variability (HRV) from 28 to 34 weeks postmenstrual age (PMA). A convenience sample of 31 low-risk preterm infants participated. HRV was quantified using a spectral analysis of heart periods and recorded during seven weekly test sessions from an electrocardiogram (ECG) signal. The total range of frequency components (0.04&ndash;2.0 Hz), high-frequency (HF) components (0.30&ndash;1.3 Hz), and ratio of low-to-high frequency (LF/HF) components (0.04&ndash;0.20/0.30&ndash;1.3 Hz) were measured. A mixed general linear model analysis revealed no significant change over weekly test sessions for the total, the high, and the ratio of LF/HF components. A significant interaction effect was, however, noted in the HF components for test session x gender (<I>df</I> = 1; <I>F</I> = 4.85; <I>p</I> = .030). With increasing age, the HF components for females increased or displayed a pattern of HRV indicative of a more mature autonomic nervous system (ANS). Study findings warrant further investigation of the impact of gender on normative descriptions of HRV.
]]></description>
<dc:creator><![CDATA[Krueger, C., van Oostrom, J., Shuster, J.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 22:46:30 PST</dc:date>
<dc:identifier>info:doi/10.1177/1099800409341175</dc:identifier>
<dc:title><![CDATA[A Longitudinal Description of Heart Rate Variability in 28-34-Week-Old Preterm Infants]]></dc:title>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409339625v1?rss=1">
<title><![CDATA[B-type Natriuretic Peptide (BNP) Is Useful in Detecting Asymptomatic Left Ventricular Dysfunction in Low-Income, Uninsured Patients]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409339625v1?rss=1</link>
<description><![CDATA[
<p>Low-income, uninsured individuals with multiple cardiovascular risk factors (CRFs) are at risk of heart failure (HF). B-type natriuretic peptide (BNP) screening for asymptomatic left ventricular dysfunction (ALVD) has not been tested specifically in this group. The purposes of this study were to describe BNP levels in asymptomatic low-income, uninsured individuals with multiple CRFs and determine the correlation between BNP levels and echocardiography for identifying ALVD. Methods: This correlational study included 53 patients (age 55 &plusmn; 10 years, 83% non-White, 64% female). BNP testing and echocardiogram (ECHO) were performed. Results: Of the 30 patients (57%) diagnosed with ALVD by ECHO, 21 (40%) had diastolic and 9 (17%) systolic dysfunction. BNP levels were lower among those with normal left ventricular (LV) function (29.6 &plusmn; 24 pg/mL) than those with diastolic (80.2 &plusmn; 69 pg/mL, <I>p</I> = .01) and systolic dysfunction (337.1 &plusmn; 374 pg/mL, <I>p</I> = .009). Participants with BNP &ge;50 pg/mL were 5.75 times more likely to exhibit diastolic dysfunction (odds ratio [OR] = 5.75, 95% confidence interval [CI] 1.29&ndash;25.51; <I>p</I> &lt; .01) and those with BNP &ge;100 pg/mL were 7.80 times more likely to have systolic dysfunction (OR = 7.8, 95% <I>CI</I> 1.60&ndash;37.14; <I>p</I> &lt; .005) than those with lower levels. With BNP cut point of 50 pg/mL, area under the curve (AUC) was 0.82 (95% CI 0.63&ndash;1.00) with sensitivity of 88% and specificity of 67%. Conclusion: BNP is a low-cost method to detect ALVD in high-risk, uninsured, low-income individuals. Elevated BNP levels should prompt initiation of further diagnostic testing and early treatment.
]]></description>
<dc:creator><![CDATA[Macabasco-O'Connell, A., Meymandi, S., Bryg, R.]]></dc:creator>
<dc:date>Mon, 23 Nov 2009 22:46:30 PST</dc:date>
<dc:identifier>info:doi/10.1177/1099800409339625</dc:identifier>
<dc:title><![CDATA[B-type Natriuretic Peptide (BNP) Is Useful in Detecting Asymptomatic Left Ventricular Dysfunction in Low-Income, Uninsured Patients]]></dc:title>
<prism:publicationDate>2009-11-23</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409348328v1?rss=1">
<title><![CDATA[Integrated Review of the Association of Cytokines With Fibromyalgia and Fibromyalgia Core Symptoms]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409348328v1?rss=1</link>
<description><![CDATA[
<p>Fibromyalgia (FMS) is a chronic widespread pain (CWP) and fatigue syndrome that affects three to six million adults in the United States. Core symptoms of FMS include pain, fatigue, and mood and sleep disturbances. To date, consensus has not been reached among researchers regarding the pathogenesis of FMS nor the specific role of cytokine activation on the neuroendocrine&ndash;immune response patterns in persons with FMS. The purpose of this article is to describe and synthesize the results of research studies focused on the relationship between cytokines and FMS and among cytokines and core symptoms of FMS. There is some support in the literature for relationships among FMS symptoms and cytokines; however, there are discrepant findings related to whether proinflammatory and anti-inflammatory cytokines are elevated or reduced in persons with FMS and whether their levels correlate with the core symptoms of this disorder. Although the use of cytokine biomarkers must be considered exploratory at this time due to the lack of consistent empirical findings, biobehavioral research focused on understanding the relationship of FMS with cytokines may lead to a better understanding of this complex syndrome. This knowledge may ultimately contribute to the development of interventions for symptom management that address not only the symptom manifestation but also a biological mediator of symptoms.
]]></description>
<dc:creator><![CDATA[Menzies, V., Lyon, D. E.]]></dc:creator>
<dc:date>Sun, 22 Nov 2009 21:07:25 PST</dc:date>
<dc:identifier>info:doi/10.1177/1099800409348328</dc:identifier>
<dc:title><![CDATA[Integrated Review of the Association of Cytokines With Fibromyalgia and Fibromyalgia Core Symptoms]]></dc:title>
<prism:publicationDate>2009-11-22</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409343311v1?rss=1">
<title><![CDATA[Antinociceptive and Antiedematogenic Activities of Andrographolide Isolated From Andrographis paniculata in Animal Models]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409343311v1?rss=1</link>
<description><![CDATA[
<p><P>The current study was performed to evaluate the antinociceptive and antiedematogenic properties of andrographolide isolated from the leaves of <I>Andrographis paniculata</I> using two animal models. Antinociceptive activity was evaluated using the acetic acid&ndash;induced writhing and the hot-plate tests, while antiedematogenic activity was measured using the carrageenan-induced paw edema test. Subcutaneous (s.c.) administration of andrographolide (10, 25, and 50 mg/kg) did not affect the motor coordination of the experimental animals but produced significant (<I>p</I> &lt; .05) antinociceptive activity when assessed using both tests. However, 2 mg/kg naloxone failed to affect the 25 mg/kg andrographolide activity in both tests, indicating that the activity was modulated via nonopioid mechanisms. Furthermore, andrographolide showed significant (<I>p</I> &lt; .05) antiedematogenic activity. In conclusion, the results obtained suggest that andrographolide has antinociceptive and antiedematogenic activities; it may be useful for treating pain and inflammation once human studies are conducted.</P>
]]></description>
<dc:creator><![CDATA[Sulaiman, Mohd. R., Zakaria, Z. A., Abdul Rahman, A., Mohamad, A. S., Desa, M. N., Stanslas, J., Moin, S., Israf, D. A.]]></dc:creator>
<dc:date>Tue, 18 Aug 2009 02:00:01 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1099800409343311</dc:identifier>
<dc:title><![CDATA[Antinociceptive and Antiedematogenic Activities of Andrographolide Isolated From Andrographis paniculata in Animal Models]]></dc:title>
<prism:publicationDate>2009-08-18</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409343204v1?rss=1">
<title><![CDATA[Perioperative Pain, Psychological Distress, and Immune Function in Men Undergoing Prostatectomy for Cancer of the Prostate]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409343204v1?rss=1</link>
<description><![CDATA[
<p><P>Prostate cancer is a leading malignancy in men, and prostatectomy is widely used for its treatment. Psychological distress and pain are commonly experienced in the perioperative period, and both can contribute to suppression of the immune response to cancer. This study evaluated perioperative pain, psychological distress, and immune function in men undergoing prostatectomy. Men were evaluated prior to surgery, 1 and 2 days postoperatively and 4&ndash;6 weeks postoperatively. Compared to cancer-free men, the prostatectomy group reported increased perceived stress, depression, confusion, and anxiety prior to surgery. During the 2 postoperative days, mood disturbance and anxiety persisted and were accompanied by mild elevations in pain and reduced vigor. At 4&ndash;6 weeks postoperative, mood, pain, and immune function were similar to those of the cancer-free group; however, the prostatectomy group continued to report significant elevations in anxiety. Natural killer cell activity (NKCA) was significantly reduced on Day 1 after prostatectomy, but by postoperative Day 2, NKCA returned to a level similar to that of the cancer-free group. The reduction in NKCA was not accompanied by changes in circulating immune cells, demonstrating that this reduction represented a functional change in NKCA. No correlations between immune variables and pain or psychological variables were found, suggesting that the postoperative reduction in NKCA was likely the result of the physical stress of the surgical experience. Suppression of immune defenses during the critical postoperative period can place cancer patients at risk for nascent tumor seeding. Additional interventions are needed to reduce this risk.</P>
]]></description>
<dc:creator><![CDATA[Yermal, S. J., Witek-Janusek, L., Peterson, J., Mathews, H. L.]]></dc:creator>
<dc:date>Sun, 09 Aug 2009 23:08:51 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1099800409343204</dc:identifier>
<dc:title><![CDATA[Perioperative Pain, Psychological Distress, and Immune Function in Men Undergoing Prostatectomy for Cancer of the Prostate]]></dc:title>
<prism:publicationDate>2009-08-09</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409340052v1?rss=1">
<title><![CDATA[Increasing of the Aminoglicosyde Antibiotic Activity Against a Multidrug-Resistant E. coli by Turnera ulmifolia L. and Chlorpromazine]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409340052v1?rss=1</link>
<description><![CDATA[
<p><P>In this study, an ethanol extract of <I>Turnera ulmifolia</I> L. (EETU) and chlorpromazine (CPZ) were tested for their antimicrobial activity alone or in combination with conventional antibiotics against two strains of <I>Escherichia coli</I> (<I>E. coli</I>). The growth of neither <I>E. coli</I> strain was inhibited by the extract. The minimal inhibitory concentration (MIC) and minimal bactericidal concentration values were &ge;1 mg/ml for both the strains of <I>E. coli</I>. However, the extract did increase the antimicrobial effects of amikacin, neomycin, and tobramycin. A similar effect of CPZ on amikacin, kanamycin, and tobramycin indicated the involvement of an efflux system in the resistance to these aminoglycosides. Results suggest that extracts from <I>T. ulmifolia</I> could be used as a plant-derived natural product with resistance-modifying activity, constituting a new weapon against bacterial resistance to antibiotics.</P>
]]></description>
<dc:creator><![CDATA[Coutinho, H. D. M., Costa, J. G. M., Lima, E. O., Falcao-Silva, V. S., Siqueira-Junior, J. P.]]></dc:creator>
<dc:date>Fri, 24 Jul 2009 02:15:57 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1099800409340052</dc:identifier>
<dc:title><![CDATA[Increasing of the Aminoglicosyde Antibiotic Activity Against a Multidrug-Resistant E. coli by Turnera ulmifolia L. and Chlorpromazine]]></dc:title>
<prism:publicationDate>2009-07-24</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409339206v1?rss=1">
<title><![CDATA[Tone-Induced Sleep Fragmentation in Persons With Alzheimer's Disease: A Feasibility Study]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409339206v1?rss=1</link>
<description><![CDATA[
<p><P>Sleep fragmentation increases as Alzheimer&rsquo;s disease (AD) progresses. Its effects on cognition, specifically vigilant attention, are profoundly important because vigilant attention is thought to be the first step in memory acquisition. To our knowledge, no one has experimentally studied the effect of sleep fragmentation on vigilant attention in persons with AD. Therefore, this study piloted an experimental method using sound (tones produced by an audiometer) to induce sleep fragmentation. Participants enrolled in the University of Arkansas for Medical Sciences Memory Research Center ([MRC] <I>n</I> = 4) underwent one night of undisturbed and one of fragmented sleep. All participants tolerated the earphone needed for the tone-induced sleep fragmentation (TISF) method, and we were able to score awakenings in real time. However, only 50% of tones produced awakenings. The findings suggest that this experimental method is feasible for use in persons with mild AD. Based on the results, we will increase the duration, intensity, and frequency of tones delivered for optimal result.</P>
]]></description>
<dc:creator><![CDATA[Cole, C. S., Richards, K., Smith-Olinde, L., Roberson, P., Sullivan, D.]]></dc:creator>
<dc:date>Fri, 17 Jul 2009 01:11:58 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1099800409339206</dc:identifier>
<dc:title><![CDATA[Tone-Induced Sleep Fragmentation in Persons With Alzheimer's Disease: A Feasibility Study]]></dc:title>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409337731v1?rss=1">
<title><![CDATA[Ambulatory Blood Pressure and Physical Activity in Heart Failure]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409337731v1?rss=1</link>
<description><![CDATA[
<p><P>This observational study used repeated measures over 24 hr to investigate ambulatory blood pressure (BP) and physical activity (PA) profiles in community-based individuals with heart failure (HF). The aims were to (a) compare BP dipping and PA between two groups of HF patients with different functional statuses, and (b) determine whether the strength of the association between ambulatory BP and PA varies by functional status in HF. Ambulatory BP was measured every 30 min with a SpaceLabs 90207; a Basic Motionlogger actigraph was used to measure PA minute-by-minute. Fifty-six participants (54% female, age 66.96 &plusmn; 12.35 years) completed data collection. Functional status was based on New York Heart Association (NYHA) ratings. Twenty-seven patients had no limitation of PA (NYHA Class I HF), whereas 29 had some limitation of PA but no discomfort at rest (NYHA Class II or III HF). Patients with Class I HF had a significantly greater degree of BP dipping than those with Class II/III HF after controlling for left ventricular ejection fraction. In a mixed-model analysis, PA was significantly related to ambulatory systolic and diastolic BP and mean arterial pressure. The strength of the association between PA and BP was not significantly different for the two groups of patients. These findings demonstrate differences between Class I and Class II/II HF in BP dipping status and ambulatory BP but not PA. Longitudinal research is recommended to improve understanding of the influence of disease progression on changes in 24-hr PA and BP profiles of patients with HF.</P>
]]></description>
<dc:creator><![CDATA[Tai, M.-K., Meininger, J., Frazier, L., Chan, W.]]></dc:creator>
<dc:date>Fri, 17 Jul 2009 01:11:58 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1099800409337731</dc:identifier>
<dc:title><![CDATA[Ambulatory Blood Pressure and Physical Activity in Heart Failure]]></dc:title>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409337526v1?rss=1">
<title><![CDATA[Comparison of Commonly Used Placement Sites for Activity Monitoring]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409337526v1?rss=1</link>
<description><![CDATA[
<p><P><I>Background:</I> No accepted standard exists to evaluate nonsleep-related activity in nursing facility residents where monitors are variously placed at the ankle, waist, wrist, thigh, or embedded in sheeting and set to record activity frequency. <I>Objectives:</I> To determine optimal placement of activity monitors by site&mdash;at the ankle, waist, or wrist for nursing facility residents. <I>Methods:</I> Nursing facility residents (<I>N</I> = 16) wore accelerometers at three sites: the nondominant ankle, waist, and wrist, while recording activity in three modes: frequency, duration, and intensity. <I>Results:</I> The natural log activity mean for each mode by site and time revealed no significant differences between the three sites for activity intensity, <I>F</I>(2, 62.78) = .15, <I>p</I> = .86; activity duration, <I>F</I>(2, 69.84) = .50, <I>p</I> = .61; and activity frequency, <I>F</I>(2, 70.04) = 1.25, <I>p</I> = .29. There were no significant site&ndash;time interactions. The natural log activity by site and mode indicated no significant differences by site for the 24-hr mean, <I>F</I>(2, 107.64) = .20, <I>p</I> = .82; activity median, <I>F</I>(2, 100.42) = .47, <I>p</I> = .63; and activity standard deviation, <I>F</I>(2, 108.69) = 1.5, <I>p</I> = .23. A significant difference was seen by site for the acceleration index, <I>F</I>(2, 106.32) = 9.57, <I>p</I> &lt; .001. No significant site&ndash;mode interactions were found. <I>Conclusions:</I> Similarity between ankle, waist, or wrist sites when measuring activity by various modes, frequency, duration, or intensity, suggests the monitors measure nonsleep-related activity equally well at any of the sites.</P>
]]></description>
<dc:creator><![CDATA[Rapp, M., Nelson, F., Oliver, M., Bergstrom, N., Cron, S.]]></dc:creator>
<dc:date>Fri, 17 Jul 2009 01:11:58 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1099800409337526</dc:identifier>
<dc:title><![CDATA[Comparison of Commonly Used Placement Sites for Activity Monitoring]]></dc:title>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409337330v1?rss=1">
<title><![CDATA[6-Sulfatoxymelatonin Collected From Infant Diapers: Feasibility and Implications for Urinary Biochemical Markers]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409337330v1?rss=1</link>
<description><![CDATA[
<p><P>The purpose of this study was to assess feasibility and acceptability of using a diaper pad for collection of in-home infant urinary samples and to test the accuracy of diaper pad extraction for 6-sulfatoxymelatonin and creatinine, which was used to correct assay results for urinary volume. To assess feasibility and acceptability, urine samples from 20 infants were collected over a 24-hr day using a cotton pad inserted in the diaper. The accuracy of diaper pad extraction was evaluated in the laboratory using urine samples collected from 11 adult volunteers and assayed using enzyme immunosorbent assay (EIA). Urine samples were divided, one aliquot was assayed without extraction, and one aliquot was instilled into a diaper pad, extracted, and assayed. Mothers found diaper pad collection acceptable and easy to perform. Of 144 infant urinary samples obtained in the home environment, 59% were usable for assay purposes, and the remaining either were contaminated with stool or were of insufficient volume. While creatinine values from diaper pad extracted and nonextracted samples were highly correlated (<I>r</I><SUP>2</SUP> = .947), those of creatinine-corrected 6-sulfatoxymelatonin were not (<I>r</I><SUP>2</SUP> = .216). Diaper pad collection procedures altered 6-sulfatoxymelatonin values. Implications for measurement of urinary biochemical substances and statistical analysis are discussed.</P>
]]></description>
<dc:creator><![CDATA[Thomas, K. A.]]></dc:creator>
<dc:date>Thu, 04 Jun 2009 22:38:14 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1099800409337330</dc:identifier>
<dc:title><![CDATA[6-Sulfatoxymelatonin Collected From Infant Diapers: Feasibility and Implications for Urinary Biochemical Markers]]></dc:title>
<prism:publicationDate>2009-06-04</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://brn.sagepub.com/cgi/content/abstract/1099800409336868v1?rss=1">
<title><![CDATA[Sleep Deprivation Impairs 12-Hr Urine Volume Excretion in Old Rats]]></title>
<link>http://brn.sagepub.com/cgi/content/abstract/1099800409336868v1?rss=1</link>
<description><![CDATA[
<p><P>Excessive nocturnal urine volumes (UVs) predict almost double the death rate in older adults. Furthermore, sleep-depriving environments may increase nocturnal UVs in old age. Thus, a pilot study was designed to examine the effects of sleep-depriving lighting treatments on the 12-hr UV excretion in young adult rats (6 months, <I>n</I> = 6), middle-aged rats (12 months, <I>n</I> = 12), old rats (16 months, <I>n</I> = 6), and old-old rats (&gt;20 months, <I>n</I> = 5). Each animal was exposed continuously to the treatments beginning with 7 days each of standard laboratory lighting conditions of on 12 hr/off 12 hr, then 7 days continuous dim lighting, and finally 7 days of continuous dim lighting plus sleep deprivation with a noxious noise. Age group and lighting condition treatments influenced 24-hr urine volume excretion (<I>F</I> (2, 29) = 2.41, <I>p</I> = .007, <I>r</I><SUP>2</SUP> = .8193). During sleep deprivation, rest-phase 12-hr urine volume excretion increased in both the old and old-old rats (<I>F</I> (2, 5) = 7.79, <I>p</I> &lt; .00001).</P>
]]></description>
<dc:creator><![CDATA[Chaperon, C.]]></dc:creator>
<dc:date>Thu, 14 May 2009 23:37:24 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1099800409336868</dc:identifier>
<dc:title><![CDATA[Sleep Deprivation Impairs 12-Hr Urine Volume Excretion in Old Rats]]></dc:title>
<prism:publicationDate>2009-05-14</prism:publicationDate>
<prism:section>Article</prism:section>
</item>

</rdf:RDF>